期刊文献+

Antiviral Activity of Medicinal Plants against Human Coronavirus: a systematic scoping review of in vitro and in vivo experimentations

原文传递
导出
摘要 OBJECTIVE:To investigate the in vitro and in vivo studies of natural compounds and medicinal plants with anti-coronavirus activity.METHODS:A systematic review was performed based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Animal Research:Reporting of in vivo experiments guidelines to find data for medicinal plants and natural products effective against human coronaviruses in in vitro or in vivo studies.Studies published up to September 6,2020 were included.Studies(in vitro or in vivo)reporting the effect of medicinal plants and natural products or their derivatives on human coronavirus were included RESULTS:Promising anti-coronavirus effects are seen with different herbal compounds like some diterpenoids,sesquiterpenoids,and three compounds in tea with 3 CLpro inhibiting effect of Severe Acute Respiratory Syndrome Coronavirus(SARS-Co V);Hirsutenone,Six cinnamic amides and bavachinin are PLpro inhibitors and Tanshinones are active on both 3 CLpro and PLpro.Some flavonoid compounds of Citrus fruits act on Immunoregulation and target angiotensin-converting enzyme 2 which is used by SARS-COV for entry.Virus helicase is possibly inhibited by two compounds myricetin and scutellarein.CONCLUSION:This review shows that complementary medicine have the potential for new drug discovery against coronavirus.Further research is needed before definitive conclusions can be made concerning the safety and efficacy of the use of these medicinal plants.
出处 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2022年第3期332-343,共12页 中医杂志(英文版)
  • 相关文献

参考文献13

二级参考文献40

  • 1中华人民共和国卫生部.传染性非典型肺炎临床诊断标准[Z].中华人民共和国卫生部办公厅,2003.5.3..
  • 2郭利民 徐道振.SARS的抗病毒治疗[N].中国医学论坛报,2003—07—10.
  • 3刘玲.中西医结合是治疗SARS的最佳选择[N].中国医学论坛报,2003—06—26.
  • 4Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome[J]. N Engl J Med, 2003,348(20):1967.
  • 5Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome [J]. N Engl J Med, 2003,348(20):1953.
  • 6Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome[J]. Lancet, 2003,361(9366):1319.
  • 7Cinatl J, Morgenstem B, Bauer G, et al. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavims[J]. Lancet, 2003, 361(9374):2045.
  • 8Donnelly CA, Ghani AC, Leung GM, et al. Epidemiological determinants of causal agent of severe acute respiratory syndrome in Hong Kong. THE LANCET. Published online 2003,May 7.
  • 9Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the Greater Toronto Area. JAMA 2003;289∶1-9.
  • 10Ksiazek TG, Erdman D, Goldsmith C, et al. A novel coronavirus associated with severe acute respiratory syndrome. New Eng J Med 2003, April 10th www. nejm. org

共引文献3220

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部